NCT06795035

Assessment of Coronary Microvascular Dysfunction After STEMI Using Continuous Saline Thermodilution

Recruiting
Not specifiedAges 18+Observational
The Cleveland Clinic
~70 participants
Updated 2025-07-31 on ClinicalTrials.gov
What's tested:Continuous Saline Thermodilution

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Microvascular resistance reserve (MRR)
Measured over At enrollment
ST Elevation Myocardial Infarction
Coronary Microvascular Dysfunction
Microvascular Obstruction
1 sites across 1 states
Ohio1
  • Khaled Ziada, MD · PRINCIPAL_INVESTIGATOR · The Cleveland Clinic

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Adults (persons \>18 years old) presenting to Cleveland Clinic cardiac catheterization lab within 24 hours of symptom onset, with clinical and EKG findings concerning for STEMI, with intent to undergo emergent primary PCI, who have culprit artery identified on diagnostic angiography
Adults (persons \>18 years old) presenting to Cleveland Clinic cardiac catheterization lab for pharmaco-invasive management of failed fibrinolysis, with intent to undergo emergent PCI, who have culprit artery identified on diagnostic angiography
On-call treating interventional cardiologist is trained in the method of continuous saline thermodilution for coronary microvascular assessment

Exclusion

No evidence of coronary obstruction on diagnostic angiography (e.g., Takotsubo, myocarditis leading to STEMI activation).
Patients in hemodynamic shock
Culprit artery \<3.0 mm in diameter.
Culprit artery being a bypass graft
Patients physically unable to tolerate additional time required to conduct coronary microvascular testing after primary PCI.
Patients with eGFR \<30 mL/min/1.73m2 are excluded from contributing cardiac MRI data
Patients with standard contraindications to CMR (e.g., pacemakers, cochlear implants, certain prosthetic heart valves, certain surgical implants) are excluded from contributing cardiac MRI data
Unable to provide verbal and written consent
Pregnancy
  • Microvascular resistance reserve (MRR)At enrollment

    Calculated index to assess coronary microvascular dysfunction (Q\_hyperemia/Q\_rest)\*(Pa\_rest/Pd\_hyperemia)